Edwards Lifesciences Corporation (BVMF:E1WL34)

Edwards Lifesciences Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	276,439	270,051	224,398	243,862	450,653	295,280
Market Cap Growth	8.12%	20.34%	-7.98%	-45.89%	52.62%	50.97%
Enterprise Value	259,061	247,284	219,045	238,302	444,465	292,137
Last Close Price	119.16	115.20	93.06	98.90	183.13	117.55
PE Ratio	37.92	10.46	32.98	30.31	53.81	69.05
PS Ratio	8.82	8.03	9.23	10.33	15.46	12.96
PB Ratio	5.08	4.34	6.88	7.94	13.86	12.43
P/TBV Ratio	7.10	6.20	9.06	10.59	18.62	18.52
P/FCF Ratio	64.50	150.61	71.94	47.38	57.51	87.84
P/OCF Ratio	51.01	80.51	51.63	37.87	46.70	53.93
EV/Sales Ratio	7.98	7.35	9.01	10.10	15.25	12.83
EV/EBITDA Ratio	25.82	24.44	27.66	26.81	46.34	39.52
EV/EBIT Ratio	28.97	27.00	30.35	29.24	50.28	42.74
EV/FCF Ratio	60.44	137.92	70.23	46.30	56.73	86.91
Debt / Equity Ratio	0.07	0.07	0.10	0.12	0.12	0.15
Debt / EBITDA Ratio	0.39	0.42	0.41	0.40	0.39	0.48
Debt / FCF Ratio	0.87	2.42	1.07	0.71	0.49	1.07
Asset Turnover	0.45	0.49	0.57	0.53	0.67	0.64
Inventory Turnover	1.14	1.12	1.10	0.90	1.63	1.50
Quick Ratio	2.98	3.13	2.06	1.87	2.07	2.24
Current Ratio	4.00	4.18	3.38	3.03	3.08	3.46
Return on Equity (ROE)	13.49%	16.64%	19.48%	22.74%	28.88%	18.88%
Return on Assets (ROA)	7.71%	8.26%	10.53%	11.47%	12.60%	11.99%
Return on Capital (ROIC)	9.54%	10.19%	13.37%	14.80%	16.81%	16.30%
Return on Capital Employed (ROCE)	13.90%	12.80%	18.20%	21.20%	21.20%	20.70%
Earnings Yield	2.64%	9.56%	3.03%	3.30%	1.86%	1.45%
FCF Yield	1.55%	0.66%	1.39%	2.11%	1.74%	1.14%
Buyback Yield / Dilution	2.54%	1.66%	2.37%	1.11%	0.11%	0.75%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.